Attached files
| file | filename |
|---|---|
| 10-Q - BRAINSTORM CELL THERAPEUTICS INC. | v166440_10q.htm |
| EX-31.2 - BRAINSTORM CELL THERAPEUTICS INC. | v166440_ex31-2.htm |
| EX-31.1 - BRAINSTORM CELL THERAPEUTICS INC. | v166440_ex31-1.htm |
| EX-32.1 - BRAINSTORM CELL THERAPEUTICS INC. | v166440_ex32-1.htm |
EXHIBIT
32.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002.
In
connection with the accompanying Quarterly Report on Form 10-Q of Brainstorm
Cell Therapeutics Inc. for the period ended September 30, 2009, the undersigned
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and
belief, that:
(1) such
Quarterly Report on Form 10-Q for the period ended September 30, 2009 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) the
information contained in such Quarterly Report on Form 10-Q for the period ended
September 30, 2009 fairly presents, in all material respects, the financial
condition and results of operations.
|
November
16, 2009
|
/s/
David Stolick
|
||
|
Name:
David Stolick
|
|||
|
Title:
Chief Financial Officer (Principal Financial Officer)
|